Antengene to Begin Phase I Clinical Study of ATG-022 for Advanced Solid Tumors
China-based Antengene Corporation Ltd (HKG: 6996) is poised to commence a Phase I clinical study...
Guangdong Zhongsheng’s RAY1225 Receives NMPA Approval for Clinical Study
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) has announced that it has received approval...
AnnJi Pharma Signs USD 250 Million Licensing Deal with Avenue Therapeutics for Kennedy’s Disease Drug
Taiwan-based AnnJi Pharmaceutical Co., Ltd has announced the signing of a licensing agreement with US...
Vcanbio’s VUM02 Gains CDE Review for Liver Failure and ARDS Clinical Trials
Vcanbio Cell & Gene Engineering Corp., Ltd (SHA: 600645) has announced that two additional clinical...
Luye Pharma’s Biosimilar BA9101 Completes Phase III Study Enrollment with Ocumension
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary, Shandong Boan Biotechnology Co., Ltd, has completed...
Immunophage Biotech Raises RMB 200 Million in Series B1 Financing for Clinical Trials
Nanjing-based Immunophage Biotech Co., Ltd reportedly raised close to RMB 200 million (USD 29.1 million)...
Akeso Biopharma Enrolls First Subject in Phase III Study of Cadonilimab for Gastric Cancer
China-based Akeso Biopharma (HKG: 9926) has announced the enrollment of the first subject in a...
CSPC Pharmaceutical’s PD-1 Monoclonal Antibody Enlangsubai Completes NMPA Market Approval Filing
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced the completion of a market approval...
Pasteur Institute Suspends Joint Venture with Chinese Academy of Sciences
France’s Pasteur Institute has announced its decision to suspend its joint-venture (JV) partnership with the...
Boston Scientific Launches REPLACE Study for FARAPULSE PFA System in China
US-based medical technology major Boston Scientific Corporation (NYSE: BSX) has announced the initiation of the...
Chipscreen’s Epidaza Receives TFDA Approval for Breast Cancer Treatment in Taiwan
Shenzhen Chipscreen Pharmaceutical Co., Ltd’s partner, GNT Biotech & Medicals Corporation, has announced that it...
Silicon Valley Bank Collapse Impacts Tech and Biotech Sectors Globally
The tech and biotech sectors are grappling with the implications of the collapse of US-based...
Allorion Therapeutics Raises USD 50 Million in Series B Financing to Advance Drug Development
Allorion Therapeutics, a next-generation precision medicine small molecule drug developer based in Guangzhou, reportedly raised...
XtalPi and Chia Tai Tianqing Achieve Phase II Milestone in Cancer Drug Development
Sino-US artificial intelligence (AI) firm XtalPi Inc. has partnered with China’s Chia Tai Tianqing to...
Overland Pharmaceuticals Partners with GoBroad Healthcare to Strengthen Cell Therapy Research
China-based firm Overland Pharmaceuticals has entered into a strategic partnership with GoBroad Healthcare Group to...
Haihe Pharmaceutical Initiates Global Phase I Clinical Study for BET-BD2 Inhibitor HH3806
Shanghai Haihe Pharmaceutical Co., Ltd has announced the first patient dosing of a global multi-center...
CanSino Biologics Initiates Phase Ib Study for Innovative Protein-Based Pneumococcal Vaccine
China-based vaccines specialist CanSino Biologics Inc. has announced the initiation and first subject enrollment of...
Zenshine Pharmaceuticals Raises RMB 100 Million in Series B Financing for Drug Development
China-based small molecule drug developer Nanjing Zenshine Pharmaceuticals Co., Ltd reportedly raised over RMB 100...
Livzon Pharmaceutical Secures Exclusive Rights to Onconic’s GERD Treatment Zastaprazan
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with South Korean...
CStone’s Ayvakit Shows Significant Improvements in ISM at AAAAI Meeting
China-based CStone Pharmaceuticals (HKG: 2616) announced that its US partner, Blueprint Medicines, published detailed data...